Cargando…

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

BACKGROUND: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Leonardi, Francesca, Londei, Davide, Padovan, Marta, Caccese, Mario, Marchione, Giulia, Bini, Silvia, Zagonel, Vittorina, Frizziero, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278095/
https://www.ncbi.nlm.nih.gov/pubmed/32550861
http://dx.doi.org/10.1177/1758835920907543

Ejemplares similares